$3.95
-0.06-1.5%
Last update: Oct 26, 3:47 PM
Vanda Pharmaceuticals Inc (VNDA) Stock Price, Quote, News & History
VNDANASDAQ
Vanda's Phase 3 trial of HETLIOZ for DSWPD met its primary endpoint, advancing sleep onset by 42.5 minutes. sNDA submission planned.
You can purchase shares of Vanda Pharmaceuticals (NASDAQ:VNDA) through any online brokerage.
Other companies in Vanda Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Vanda Pharmaceuticals has a consensus price target of $13.07.
The stock price for Vanda Pharmaceuticals (NASDAQ: VNDA) is $3.95 last updated October 26, 2026 at 3:47 PM EDT.
There are no upcoming dividends for Vanda Pharmaceuticals.
Vanda Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Vanda Pharmaceuticals.
Vanda Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ...
